Publications by authors named "Ian Laster"

Claim this Profile
B
Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.
Oladapo O Yeku, Thapi Dharma Rao, Ian Laster, Artem Kononenko, Terence J Purdon

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies.
Marina Stasenko, Evan Smith, Oladapo Yeku, Kay J Park, Ian Laster

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis